Despite the success of various anti‐EGFR mAb‐based strategies for overcoming cetuximab resistance in EGFR‐positive cancer treatment, the development of a novel strategy that incorporate multiple molecular mechanisms to overcome cetuximab resistance may improve therapeutic efficacy and index in cancer treatment. Here, EGFR is linked to cancer.